Status:
COMPLETED
Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Juvenile Rheumatoid Arthritis
Eligibility:
All Genders
6-18 years
Phase:
PHASE2
Brief Summary
This study looks at the effects of taking calcium pills on bone health in young people with juvenile rheumatoid arthritis (JRA). In this 2-year study, children aged 6-18 who have JRA will take either ...
Detailed Description
This is a randomized, double-blind, placebo-controlled trial of 24 months in which juvenile rheumatoid arthritis (JRA) patients will take either an oral calcium supplement of 1,000 mg elemental calciu...
Eligibility Criteria
Inclusion Criteria:
- JRA Diagnosis by American College of Rheumatology diagnostic criteria
- Age 6-18 years
Exclusion Criteria:
- Taking calcium supplements or calcium- containing antacids
- Taken systemic corticosteroids in the prior 3 months
- Use of oral contraceptives
- Smoker
- Have been or currently pregnant
- Have another chronic illness that affects growth or bone mineralization (for example, Down's Syndrome, inflammatory bowel disease, steroid-dependent asthma)
- Fasting random urinary calcium/creatinine ratio > 0.2
Key Trial Info
Start Date :
June 1 1996
Trial Type :
INTERVENTIONAL
End Date :
May 1 2001
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00000429
Start Date
June 1 1996
End Date
May 1 2001
Last Update
August 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229